Tate & Lyle plc

Tate & Lyle plc

TATYY
Tate & Lyle plcUS flagOther OTC
30.13
USD
- -
- -
7.14BMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
Revenue per Share
27.69
23.53
23.67
27.68
27.36
27.79
28.97
12.17
13.8
17.33
16.59
- -
18.14
Basic EPS, GAAP
2.75
0.3
1.64
2.57
2.68
1.83
2.46
2.54
2.37
1.88
1.89
- -
0.88
Free Cash Flow per Basic Share
1.4
0.24
-0.1
1.46
1.56
2.02
2.19
2.18
-0.45
-0.12
0.99
- -
0.95
Dividend per Share
1.25
1.31
1.31
1.31
1.32
1.35
1.38
1.38
1.44
5.64
0.77
- -
0.8
Book Value per Share
5.8
4.62
4.89
6.69
8.01
8.66
7.5
8.99
9.85
6.24
7.45
- -
5.72
Tangible Book Value per Share
7.47
5.99
6.42
9.36
10.17
11.57
10.65
11.15
13.47
7.31
8.39
- -
7.27
Basic Weighted Avg Shares
99
99
99
99
99
99
99
99
100
101
99
- -
111
Sales/Revenue/Turnover
2,754
2,341
2,355
2,753
2,710
2,755
2,882
1,211
1,375
1,751
1,647
1,736
2,006
Operating Margin (%)
9.37
7.48
7.52
9.52
10.52
10.74
11.17
12.72
12.07
13.02
14.27
6.11
12.16
Depreciation Expense
103
109
115
149
154
152
172
175
100
95
94
128
172
Net Income, GAAP
273
30
163
256
265
181
245
253
236
190
188
143
97
Effective Tax Rate (%)
11.55
84
3.17
- -
8.04
24.58
17.23
1.11
38.1
16.45
20.4
48.86
25.19
Profit Margin (%)
9.91
1.28
6.92
9.3
9.78
6.57
8.5
20.89
17.16
10.85
11.41
8.24
4.84
Working Capital
356
226
414
538
526
415
624
745
1,680
712
749
684
841
LT Debt
435
461
554
602
552
371
680
744
656
592
573
1,145
1,274
Total Equity
1,050
936
1,029
1,332
1,367
1,489
1,399
1,454
1,620
1,190
1,239
1,588
1,598
Return on Invested Capital (%)
12.04
1.57
9.57
- -
12.96
10.89
12.49
6.92
4.5
8.94
9.79
2.26
6.21
Return on Capital (%)
22.71
2.74
15.48
- -
21.74
14.52
18.66
17.78
15.09
14.43
15.54
10.19
7.22
Return on Common Equity (%)
51.51
5.79
34.42
44.44
36.33
21.91
30.55
30.85
25.16
23.57
27.45
21.15
15.58

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
5.67%
3.56%
0.63%
Free Cash Flow
-252.82%
-204.53%
144.19%
Net Income, GAAP
-1.59%
-16.67%
-32.17%
Sales/Revenue/Turnover
1.95%
11.18%
15.55%
Total Cash Common Dividend
- -
45.91%
10%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
1,647
2025
- -
- -
- -
- -
1,736
2026
- -
- -
- -
- -
2,006

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
1.89
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
0.88

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.77
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
0.8

Company Description

APIChatGPT
CEO
Anthony Nicholas Seymour Hampton
Full Time Employees
4,840
Sector
Consumer Defensive
Industry
Packaged Foods
Address
5 Marble Arch London LO United Kingdom W1H 7EJ
IPO Date
Nov 18, 1996
Business
Tate & Lyle plc is a specialty food and beverage solutions company that manufactures and supplies a broad range of ingredients including sweeteners, functional starches, dietary fibers, and specialty food additives. The company operates through four core business segments: Food & Beverage Solutions, Sucralose, Primary Products Europe, and CP Kelco. Its product portfolio includes high-intensity sweeteners such as SPLENDA Sucralose and TASTEVA Stevia Sweetener; functional clean label starches like CLARIA; soluble fibers under PROMITOR; crystalline fructose branded as KRYSTAR; and nature-based ingredients such as pectin and specialty gums, primarily through its CP Kelco segment. Tate & Lyle serves global markets including beverages; dairy; soups, sauces, and dressings; bakery and snacks; confectionery; meat and seafood; personal care; household; clinical nutrition; and industrial applications. Founded in 1903 and headquartered in London, United Kingdom, Tate & Lyle has undergone significant transformation in recent years, focusing on becoming a growth-oriented specialty ingredient supplier. The most notable recent change is the acquisition of CP Kelco in June 2024, a major global provider of pectin and specialty gums, which expanded Tate & Lyle’s product and geographic reach significantly. This acquisition aligns with the company’s strategic emphasis on natural, sustainable ingredients and solution-based innovation. In addition, Tate & Lyle has increased investment in product innovation and capacity expansion to meet growing consumer demand for healthier, lower-calorie, and clean-label foods and beverages. Other recent operational moves include a £216 million share buyback funded by proceeds from divestments, signaling capital return discipline and confidence in ongoing strategic execution. Tate & Lyle’s specialty ingredients help customers reduce sugar and calories, enhance mouthfeel, and fortify products with dietary fiber and protein. The company actively pursues value-creative acquisitions and partnerships to strengthen its portfolio and capabilities in sensory applications and open innovation. With over 4,900 employees globally and operations in more than 60 locations worldwide, Tate & Lyle targets multiple consumer-focused industries with a clear business model centered on specialty food ingredients and solutions for health-conscious consumer trends.

Company News

APIChatGPT
  • Ingredion to Take Over Tate & Lyle in $3.6 Billion Deal

  • Tate & Lyle agrees £3.8bn takeover by US rival

  • Ingredion Announces Recommended All-Cash Acquisition of Tate & Lyle

  • UK's Tate & Lyle agrees $3.6 billion Ingredion takeover

  • Tate & Lyle plc (TATYY) Q4 2026 Earnings Call Transcript

  • Tate & Lyle H2 Earnings Call Highlights

  • Ingredion Takeover Target Tate & Lyle Posts Fall in Profit

  • BioHarvest Sciences and Tate & Lyle expand sweetener development program

  • Tate & Lyle is a sweet opportunity for bidders says broker

  • Tate & Lyle In Talks With Ingredion Over $3.7 billion Takeover Offer

  • Britain's Tate & Lyle in discussions with US rival Ingredion for $3.7 billion takeover bid

  • Tate & Lyle (OTCMKTS:TATYY) Shares Gap Up – Should You Buy?

  • Critical Contrast: Armanino Foods of Distinction (OTCMKTS:AMNF) & Tate & Lyle (OTCMKTS:TATYY)

  • Tate & Lyle (OTCMKTS:TATYY) versus Kraft Heinz (NASDAQ:KHC) Head-To-Head Survey

  • Head to Head Contrast: Ingredion (NYSE:INGR) and Tate & Lyle (OTCMKTS:TATYY)

  • Tate & Lyle (OTCMKTS:TATYY) Shares Gap Down – Should You Sell?

  • Tate & Lyle plc (TATYY) Q3 2026 Earnings Call Transcript

  • Tate & Lyle PLC (OTCMKTS:TATYY) Given Average Recommendation of “Hold” by Analysts

  • Reviewing Tate & Lyle (OTCMKTS:TATYY) and Greenlane (NASDAQ:GNLN)

  • Tate & Lyle PLC (OTCMKTS:TATYY) Receives Average Rating of “Hold” from Analysts